Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers

Felton, TW, Ogungbenro, K, Boselli, E, Hope, WW ORCID: 0000-0001-6187-878X and Rodvold, KA (2018) Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73 (5). pp. 1340-1347.

Text HV versus Patients piperacillin revsied.docx - Author Accepted Manuscript Download (1MB)

Abstract

<h4>Background</h4>Severe infections of the respiratory tracts of critically ill patients are common and associated with excess morbidity and mortality. Piperacillin is commonly used to treat pulmonary infections in critically ill patients. Adequate antibiotic concentration in the epithelial lining fluid (ELF) of the lung is essential for successful treatment of pulmonary infection.<h4>Objectives</h4>To compare piperacillin pharmacokinetics/pharmacodynamics in the serum and ELF of healthy volunteers and critically ill patients.<h4>Methods</h4>Piperacillin concentrations in the serum and ELF of healthy volunteers and critically ill patients were compared using population methodologies.<h4>Results</h4>Median piperacillin exposure was significantly higher in the serum and the ELF of critically ill patients compared with healthy volunteers. The IQR for serum piperacillin exposure in critically ill patients was six times greater than for healthy volunteers. The IQR for piperacillin exposure in the ELF of critically ill patients was four times greater than for healthy volunteers. The median pulmonary piperacillin penetration ratio was 0.31 in healthy volunteers and 0.54 in critically ill patients.<h4>Conclusions</h4>Greater variability in serum and ELF piperacillin concentrations is observed in critically ill patients compared with healthy adult subjects and must be considered in the development of dosage regimens. Pulmonary penetration of antimicrobial agents should be studied in critically ill patients, as well as healthy volunteers, during drug development to ensure appropriate dosing of patients with pneumonia.

Item Type:	Article
Uncontrolled Keywords:	Lung, Serum, Humans, Critical Illness, Piperacillin, Anti-Bacterial Agents, Adult, Middle Aged, Female, Male, Young Adult, Healthy Volunteers
Depositing User:	Symplectic Admin
Date Deposited:	12 Feb 2018 08:54
Last Modified:	13 Feb 2024 09:24
DOI:	10.1093/jac/dkx541
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3017951